Brian L. Koopman - 27 Oct 2021 Form 4 Insider Report for UTAH MEDICAL PRODUCTS INC (UTMD)

Role
Principal Financial Officer
Signature
/s/ Brian L. Koopman
Issuer symbol
UTMD
Transactions as of
27 Oct 2021
Net transactions value
+$103
Form type
4
Filing time
28 Oct 2021, 11:19:05 UTC
Previous filing
28 Oct 2021
Next filing
25 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTMD Common Stock Tax liability $43,135 -433 -71% $99.62 174 27 Oct 2021 Direct
transaction UTMD Common Stock Options Exercise $3,049 +62 +36% $49.18 236 27 Oct 2021 Direct
transaction UTMD Common Stock Options Exercise $40,190 +687 +291% $58.50 923 27 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTMD Employee Stock Option - Right to Buy Options Exercise $0 -62 -1.7% $0.000000 3,600 27 Oct 2021 Common Stock 62 $49.18 Direct F1
transaction UTMD Employee Stock Option - Right to Buy Options Exercise $0 -687 -16% $0.000000 3,600 27 Oct 2021 Common Stock 687 $58.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vested 25% on 4/1/2015, and at an additional 6.25% on 7/1/2015 and the first day of each calendar quarter thereafter. Of shares exercised the most recent vesting date was 4/1/2018.
F2 Option vested 25% on 10/1/2017, and at an additional 6.25% on 1/1/2018 and the first day of each calendar quarter thereafter. Of shares exercised the most recent vesting date was 10/1/2020.